Visus Therapeutics, Zhaoke Ophthalmology partner on presbyopia drops in Asian markets

Companies are entering an exclusive licensing agreement for the development and commercialization of Brimochol PF and Carbachol PF in three new regions: Greater China, South Korea, and select Southeast Asian territories.

MacuLogix marks 1 million dark adaptation tests

The company's technology allows for ECPs to detect, monitor, and treat AMD 3 years before clinical diagnosis.

What’s hot (and not) in retinal news

A look at the latest developments in retinal disease, including clinical trials and advanced therapies.